Cargando…
Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas
Recently, two cases of complete remission of classical Hodgkin lymphoma (cHL) and follicular lymphoma (FL) after SARS-CoV-2 infection were reported. However, the precise molecular mechanism of this rare event is yet to be understood. Here, we hypothesize a potential anti-tumor immune response of SAR...
Autores principales: | Barh, Debmalya, Tiwari, Sandeep, Gabriel Rodrigues Gomes, Lucas, Weener, Marianna E., Alzahrani, Khalid J., Alsharif, Khalaf F., Aljabali, Alaa A. A., Tambuwala, Murtaza M., Lundstrom, Kenneth, Hassan, Sk. Sarif, Serrano-Aroca, Ángel, Takayama, Kazuo, Ghosh, Preetam, Redwan, Elrashdy M., Silva Andrade, Bruno, Soares, Siomar de Castro, Azevedo, Vasco, Uversky, Vladimir N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539762/ https://www.ncbi.nlm.nih.gov/pubmed/34696358 http://dx.doi.org/10.3390/v13101927 |
Ejemplares similares
-
Would New SARS-CoV-2 Variants Change the War against COVID-19?
por: Redwan, Elrashdy M., et al.
Publicado: (2022) -
COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence
por: Hromić-Jahjefendić, Altijana, et al.
Publicado: (2023) -
Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management
por: Barh, Debmalya, et al.
Publicado: (2021) -
COVID-19 signalome: Potential therapeutic interventions
por: Lundstrom, Kenneth, et al.
Publicado: (2023) -
SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based Approach
por: Barh, Debmalya, et al.
Publicado: (2022)